Journal
JOURNAL OF CLINICAL MICROBIOLOGY
Volume 57, Issue 2, Pages -Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/JCM.00906-18
Keywords
bronchiectasis; cystic fibrosis; Mycobacterium talmoniae
Categories
Ask authors/readers for more resources
We characterize three respiratory isolates of the recently described species Mycobacterium talmoniae recovered in Texas, Louisiana, and Massachusetts, including the first case of disease in a patient with underlying cystic fibrosis. The three isolates had a 100% match to M. talmoniae NE-TNMC-100812(T) by complete 16S rRNA, rpoB region V, and hsp65 gene sequencing. Core genomic comparisons between one isolate and the type strain revealed an average nucleotide identity of 99.8%. The isolates were susceptible to clarithromycin, amikacin, and rifabutin, while resistance was observed for tetracyclines, ciprofloxacin, and linezolid. M. talmoniae should be added to the list of potential pulmonary pathogens, including in the setting of cystic fibrosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available